Decoding In Vitro Oncology Innovations: Organoids, OMICs, and Their Role in Early Drug Discovery and Clinical Applications

Our upcoming webinar explores the dynamic intersection of technology and biology, where in vitro tools and OMICs applications unravel mechanism of action, drug discovery and clinical translation.

What We’ll Cover:

• Strengths and Weaknesses of In Vitro Tools: We’ll discuss an array of in vitro tools including tumor cell lines, organoids, 3D cultures, high throughput screens (HTS) and their respective merits and limitations in the context of clinical translation.
• In Vitro Models for Biomarkers Discovery: Here we’ll delve into 2D and 3D models including cell lines and organoids. Our focus will be on their utility in discovering biomarkers and signature responses, crucial for informed in vivo modelling and patient stratification in clinical settings.
• Application of OMICs in Early Drug Discovery: Together we will explore the role of OMICs applications, with a particular focus on tumor organoids and organoid screening in the early stages of drug discovery.

Dive into this transformative field with us and register today.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.